Levodopa‐induced ocular dyskinesias in Parkinson's disease
Identifieur interne : 004402 ( Main/Exploration ); précédent : 004401; suivant : 004403Levodopa‐induced ocular dyskinesias in Parkinson's disease
Auteurs : Gurutz Linazasoro [Espagne] ; Nadege Van Blercom [Espagne] ; Asier Lasa [Espagne] ; Bego A Indakoetxea [Espagne] ; Javier Ruiz [Espagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2002-01.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Adulte.
English descriptors
- KwdEn :
- Adult, Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Antiparkinson agent, Case study, Chemotherapy, Diagnosis, Differential, Dyskinesia, Gaze, Humans, Levodopa, Levodopa (adverse effects), Levodopa (therapeutic use), Male, Middle Aged, Ocular Motility Disorders (chemically induced), Ocular Motility Disorders (diagnosis), Parkinson Disease (drug therapy), Parkinson disease, Pathogenesis, Toxicity, Treatment.
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Levodopa.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- chemically induced : Ocular Motility Disorders.
- diagnosis : Ocular Motility Disorders.
- drug therapy : Parkinson Disease.
- Diagnosis, Differential, Humans, Male, Middle Aged.
Abstract
Levodopa‐induced ocular dyskinesias are very uncommon. Usually they occur simultaneously with limb peak‐dose choreatic dyskinesias. We report on a patient with leftward and upward deviations of gaze during the peak effect of levodopa, and hypothesize that a severe dopaminergic denervation in the caudate nucleus is needed for the appearance of these levodopa‐induce ocular dyskinesias. © 2001 Movement Disorder Society.
Url:
DOI: 10.1002/mds.10017
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001B24
- to stream Istex, to step Curation: 001B24
- to stream Istex, to step Checkpoint: 002C93
- to stream Main, to step Merge: 006407
- to stream PascalFrancis, to step Corpus: 002823
- to stream PascalFrancis, to step Curation: 000498
- to stream PascalFrancis, to step Checkpoint: 002707
- to stream Main, to step Merge: 006746
- to stream PubMed, to step Corpus: 003B78
- to stream PubMed, to step Curation: 003B78
- to stream PubMed, to step Checkpoint: 003A39
- to stream Ncbi, to step Merge: 000673
- to stream Ncbi, to step Curation: 000673
- to stream Ncbi, to step Checkpoint: 000673
- to stream Main, to step Merge: 006172
- to stream Main, to step Curation: 004402
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Levodopa‐induced ocular dyskinesias in Parkinson's disease</title><author><name sortKey="Linazasoro, Gurutz" sort="Linazasoro, Gurutz" uniqKey="Linazasoro G" first="Gurutz" last="Linazasoro">Gurutz Linazasoro</name></author><author><name sortKey="Van Blercom, Nadege" sort="Van Blercom, Nadege" uniqKey="Van Blercom N" first="Nadege" last="Van Blercom">Nadege Van Blercom</name></author><author><name sortKey="Lasa, Asier" sort="Lasa, Asier" uniqKey="Lasa A" first="Asier" last="Lasa">Asier Lasa</name></author><author><name sortKey="Indakoetxea, Bego A" sort="Indakoetxea, Bego A" uniqKey="Indakoetxea B" first="Bego A" last="Indakoetxea">Bego A Indakoetxea</name></author><author><name sortKey="Ruiz, Javier" sort="Ruiz, Javier" uniqKey="Ruiz J" first="Javier" last="Ruiz">Javier Ruiz</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6EDFFBF599B518968D3C2CE1263BC44568FC2B39</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1002/mds.10017</idno><idno type="url">https://api.istex.fr/document/6EDFFBF599B518968D3C2CE1263BC44568FC2B39/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001B24</idno><idno type="wicri:Area/Istex/Curation">001B24</idno><idno type="wicri:Area/Istex/Checkpoint">002C93</idno><idno type="wicri:doubleKey">0885-3185:2002:Linazasoro G:levodopa:induced:ocular</idno><idno type="wicri:Area/Main/Merge">006407</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:02-0206614</idno><idno type="wicri:Area/PascalFrancis/Corpus">002823</idno><idno type="wicri:Area/PascalFrancis/Curation">000498</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002707</idno><idno type="wicri:doubleKey">0885-3185:2002:Linazasoro G:levodopa:induced:ocular</idno><idno type="wicri:Area/Main/Merge">006746</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:11835460</idno><idno type="wicri:Area/PubMed/Corpus">003B78</idno><idno type="wicri:Area/PubMed/Curation">003B78</idno><idno type="wicri:Area/PubMed/Checkpoint">003A39</idno><idno type="wicri:Area/Ncbi/Merge">000673</idno><idno type="wicri:Area/Ncbi/Curation">000673</idno><idno type="wicri:Area/Ncbi/Checkpoint">000673</idno><idno type="wicri:doubleKey">0885-3185:2002:Linazasoro G:levodopa:induced:ocular</idno><idno type="wicri:Area/Main/Merge">006172</idno><idno type="wicri:Area/Main/Curation">004402</idno><idno type="wicri:Area/Main/Exploration">004402</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Levodopa‐induced ocular dyskinesias in Parkinson's disease</title><author><name sortKey="Linazasoro, Gurutz" sort="Linazasoro, Gurutz" uniqKey="Linazasoro G" first="Gurutz" last="Linazasoro">Gurutz Linazasoro</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Neurología y Neurocirugía funcional Clínica Quirón San Sebastián</wicri:regionArea></affiliation></author><author><name sortKey="Van Blercom, Nadege" sort="Van Blercom, Nadege" uniqKey="Van Blercom N" first="Nadege" last="Van Blercom">Nadege Van Blercom</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Neurología y Neurocirugía funcional Clínica Quirón San Sebastián</wicri:regionArea></affiliation></author><author><name sortKey="Lasa, Asier" sort="Lasa, Asier" uniqKey="Lasa A" first="Asier" last="Lasa">Asier Lasa</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Neurología y Neurocirugía funcional Clínica Quirón San Sebastián</wicri:regionArea></affiliation></author><author><name sortKey="Indakoetxea, Bego A" sort="Indakoetxea, Bego A" uniqKey="Indakoetxea B" first="Bego A" last="Indakoetxea">Bego A Indakoetxea</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Neurología y Neurocirugía funcional Clínica Quirón San Sebastián</wicri:regionArea></affiliation></author><author><name sortKey="Ruiz, Javier" sort="Ruiz, Javier" uniqKey="Ruiz J" first="Javier" last="Ruiz">Javier Ruiz</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Neurología y Neurocirugía funcional Clínica Quirón San Sebastián</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="2002-01">2002-01</date><biblScope unit="vol">17</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="186">186</biblScope><biblScope unit="page" to="187">187</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">6EDFFBF599B518968D3C2CE1263BC44568FC2B39</idno><idno type="DOI">10.1002/mds.10017</idno><idno type="ArticleID">MDS10017</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antiparkinson Agents (adverse effects)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Antiparkinson agent</term><term>Case study</term><term>Chemotherapy</term><term>Diagnosis, Differential</term><term>Dyskinesia</term><term>Gaze</term><term>Humans</term><term>Levodopa</term><term>Levodopa (adverse effects)</term><term>Levodopa (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Ocular Motility Disorders (chemically induced)</term><term>Ocular Motility Disorders (diagnosis)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson disease</term><term>Pathogenesis</term><term>Toxicity</term><term>Treatment</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Ocular Motility Disorders</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Ocular Motility Disorders</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Adulte</term><term>Antiparkinsonien</term><term>Chimiothérapie</term><term>Dyskinésie</term><term>Etude cas</term><term>Lévodopa</term><term>Mâle</term><term>Parkinson maladie</term><term>Pathogénie</term><term>Regard</term><term>Toxicité</term><term>Traitement</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adulte</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Levodopa‐induced ocular dyskinesias are very uncommon. Usually they occur simultaneously with limb peak‐dose choreatic dyskinesias. We report on a patient with leftward and upward deviations of gaze during the peak effect of levodopa, and hypothesize that a severe dopaminergic denervation in the caudate nucleus is needed for the appearance of these levodopa‐induce ocular dyskinesias. © 2001 Movement Disorder Society.</div></front></TEI><affiliations><list><country><li>Espagne</li></country></list><tree><country name="Espagne"><noRegion><name sortKey="Linazasoro, Gurutz" sort="Linazasoro, Gurutz" uniqKey="Linazasoro G" first="Gurutz" last="Linazasoro">Gurutz Linazasoro</name></noRegion><name sortKey="Indakoetxea, Bego A" sort="Indakoetxea, Bego A" uniqKey="Indakoetxea B" first="Bego A" last="Indakoetxea">Bego A Indakoetxea</name><name sortKey="Lasa, Asier" sort="Lasa, Asier" uniqKey="Lasa A" first="Asier" last="Lasa">Asier Lasa</name><name sortKey="Ruiz, Javier" sort="Ruiz, Javier" uniqKey="Ruiz J" first="Javier" last="Ruiz">Javier Ruiz</name><name sortKey="Van Blercom, Nadege" sort="Van Blercom, Nadege" uniqKey="Van Blercom N" first="Nadege" last="Van Blercom">Nadege Van Blercom</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004402 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004402 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6EDFFBF599B518968D3C2CE1263BC44568FC2B39
|texte= Levodopa‐induced ocular dyskinesias in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |